Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…day and venlafaxine 300 mg/day. Relevant comorbidities included benign prostatic hyperplasia and orthostatic hypotension.Material and Methods During hospita…
…25% (27 interventions)Antihypertensives – 12% (13 interventions)Antibiotics – 9% (10 interventions)27% (n=29) of deprescribing intervention…
…ilisin/kexin type 9 inhibitors (PCSK9i), such as alirocumab and evolocumab, effectively manage cLDL levels. However, the relative efficacy…
…gical and surgical, and the drugs most frequently involved were acetaminophen (n=8), metamizole (n=6) and amoxicillin-clavulanic acid (n=5); …
…ry mediastinal large B-cell lymphoma (LBMP) in 2.9% of patients.ECOG performance status was 0 in 80.8%, 1 in 15.4%, and 2 in 3.8% of patients.Patients …
…ase describes severe immune-mediated toxicity after one dose of ipilimumab (1 mg/kg) and nivolumab (3 mg/kg) in a stage IV patient who dev…
…pital and community prescribers were observed, particularly for doxycycline (consumption increased at UH-1 while decreasing in its region) …
…s In 06/2025, the patient began treatment with tremelimumab and durvalumab. Three weeks after the first cycle he developped cough and desa…
…s it can cause lethargy. Within 24h, he deteriorated to stupor (Glasgow Coma Scale 4), responding only to painful stimuli, with generalised rigidi…
…Background and Importance Treatment burden in neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME) is an issue for patien…
…% sensitivity, 95% specificity, and 95% accuracy for diagnosing CA-A1. Distal embolism into the ipsilateral ACA was more frequent in …
…Background A1 hypoplasia is associated with anterior communicating artery (AcomA) aneury…